TOKYO -- Japanese drugmaker Daiichi Sankyo said Friday it plans to make cancer treatments in China in response to growing demand there.
Pharmaceuticals
Japan's Daiichi Sankyo to make cutting-edge cancer treatments in China
Company behind breast cancer drug Enhertu to spend $152m on new production facility
Enhertu from Daiichi Sankyo and AstraZeneca has been approved in China to treat some forms of breast cancer. (Daiichi Sankyo)
Read Next
Latest on Pharmaceuticals
